News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Nebius shares pulled back from June highs, presenting a tactical buying opportunity.
  • The company shows an explosive revenue ramp supporting the valuation case.
  • Nebius owns its infrastructure, supporting operational control and scalable capacity.
  • Improving order books point to stronger near-term demand.
  • Recommended trade: buy at $168, stop at $140, target $240 over a 180-day campaign.
  • Plan explicitly sizes positions for elevated execution and macro risks.

Latest Articles

Fluence: Buy the Factory Catch-Up Trade as Orders Outpace Production

Fluence: Buy the Factory Catch-Up Trade as Orders Outpace Production

Fluence’s backlog and strategic partnership with Nvidia point to solid demand from AI data centers and utilities. The stock trades at $11.04 with a market cap around $2.04B, negative free cash flow, and meaningful short interest. This idea is a directional long that exploits an expected re-rating if manufacturing throughput and margins begin to nor…

Credo: Buy the AI Connectivity Pullback - Tactical Long (Upgrade)

Credo: Buy the AI Connectivity Pullback - Tactical Long (Upgrade)

Credo has the connectivity products that matter to hyperscale AI clusters. Recent sell-offs reflect margin noise and concentration fears, but the company's top-line is accelerating sharply: Q1 revenue $479M (+114.7% YoY) and FY2026 revenue topped $1.3B. At $167.86 the stock underprices a multi-year shift to higher-speed optics and near-package conn…

Rail Vision Introduces TrackScout and YardFlow Flex as New Brand Names for its Mainline and Switchyard Solutions

Rail Vision Introduces TrackScout and YardFlow Flex as New Brand Names for its Mainline and Switchyard Solutions

Rail Vision Ltd. announced the rebranding of its MainLine and ShuntingYard AI-powered railway safety products to TrackScout and YardFlow Flex, respectively. These advanced AI perception systems enhance hazard detection and operational efficiency in mainline rail networks and industrial rail yards, supported by Rail Vision's operational intelligence…

Sell the S&P Hype: Short Bloom Energy on Upgrade Momentum

Sell the S&P Hype: Short Bloom Energy on Upgrade Momentum

Bloom Energy (BE) sports strong momentum and a fresh upgrade that could attract S&P inclusion flows, but the stock's premium valuation, pending supply-chain litigation, and the need to convert backlog into durable cash argue for a tactical short on a rally. Entry $285.00, target $230.00, stop $305.00. Mid-term horizon (45 trading days).

Palvella Therapeutics Appoints James R. Treat, M.D., Nationally Recognized Pediatric Dermatologist as Chief Medical Officer

Palvella Therapeutics Appoints James R. Treat, M.D., Nationally Recognized Pediatric Dermatologist as Chief Medical Officer

Palvella Therapeutics has appointed Dr. James R. Treat, a nationally recognized pediatric dermatologist with nearly 20 years of experience, as Chief Medical Officer. Dr. Treat has been a longstanding clinical collaborator and investigator in Palvella's QTORIN™ trials and will lead the company’s medical strategy as they advance the potential approva…

America's Car-Mart Reports First Quarter Fiscal Year 2027 Results

America's Car-Mart Reports First Quarter Fiscal Year 2027 Results

America’s Car-Mart, Inc. reported its first quarter fiscal 2027 financial results, showing severe declines in retail unit sales and revenue, primarily due to capital constraints limiting inventory purchases and finance receivables originations. The company sold 81.9% fewer retail units compared to the prior year, with inventory down 68.7%. The gros…

NervGen to Host Inaugural R&D Day on September 30, 2026

NervGen to Host Inaugural R&D Day on September 30, 2026

NervGen, a NASDAQ-listed biopharmaceutical company, announced its inaugural R&D Day webcast to provide a comprehensive update on its lead neuroreparative drug candidate NVG-291. The event will feature detailed presentations on the science, clinical data, and upcoming Phase 3 RESTORE trial designed to treat chronic cervical spinal cord injury. Exper…

FTI Consulting Strengthens Construction Disputes Capabilities in Latin America With Appointment of Luis Roman

FTI Consulting Strengthens Construction Disputes Capabilities in Latin America With Appointment of Luis Roman

FTI Consulting, Inc. has appointed Luis Roman as Senior Managing Director to strengthen its Construction, Projects & Assets practice, particularly in Latin America. Mr. Roman brings over 30 years of construction and project management experience with expertise in construction forensics and dispute resolution. His appointment aims to support clients…

Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York

Helus Pharma to Participate at the H.C. Wainwright 28th Annual Global Investment Conference in New York

Helus Pharma, a clinical-stage pharmaceutical company focusing on novel serotonergic agonists (NSAs) for mental health conditions, announced that its CEO Michael Halstead will participate in a fireside chat at the H.C. Wainwright 28th Annual Global Investment Conference. The company is advancing its lead compounds HLP003 in Phase 3 for major depres…

Kremlin Says It Seeks Quick Resumption of U.S.-Mediated Ukraine Talks

Kremlin Says It Seeks Quick Resumption of U.S.-Mediated Ukraine Talks

The Kremlin said it hopes U.S.-mediated negotiations aimed at ending the war in Ukraine will restart soon. Kremlin spokesman Dmitry Peskov cited a "confirmed political will" to resume talks and said contacts with U.S. counterparts continue following negotiator visits and a telephone call between the presidents. Prisoner exchanges between Russia and…

Coloplast Shares Drop After JPMorgan Lowers Rating and Cuts Price Target

Coloplast Shares Drop After JPMorgan Lowers Rating and Cuts Price Target

Coloplast shares slid following a substantial downgrade from JPMorgan, which shifted its rating to Underweight and lowered its December 2027 price target to DKK 377 from DKK 484. The bank highlighted a stretched valuation, potential changes to mid-term targets under new leadership, and weakened margins in the third quarter as primary concerns, cont…

Sunbelt Rentals Pops After Record Quarter, Guidance Raise and New Dividend

Sunbelt Rentals Pops After Record Quarter, Guidance Raise and New Dividend

Sunbelt Rentals Holdings Inc. shares climbed in pre-market trading after the company reported record first-quarter fiscal 2027 results, with rental revenue rising 11.2% and revenue beating analyst expectations for the period ended July 31, 2026. Management increased full-year fiscal 2027 guidance and announced a regular quarterly dividend; the rece…